Results 221 to 230 of about 326,995 (379)

TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer. [PDF]

Cell Rep Med, 2021
Beatson RE, Parente-Pereira AC, Halim L, Cozzetto D, Hull C, Whilding LM, Martinez O, Taylor CA, Obajdin J, Luu Hoang KN, Draper B, Iqbal A, Hardiman T, Zabinski T, Man F, de Rosales RTM, Xie J, Aswad F, Achkova D, Joseph CR, Ciprut S, Adami A, Roider HG, Hess-Stumpp H, Győrffy B, Quist J, Grigoriadis A, Sommer A, Tutt ANJ, Davies DM, Maher J.   +30 more
europepmc   +1 more source

Essential Updates 2023/2024: Recent Advances of Multimodal Approach in Patients for Gastric Cancer

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Gastric cancer remains a major global health burden, especially in East Asia. Recent years have brought significant advances in multimodal management, including surgery, perioperative chemotherapy, immunotherapy, and supportive care. This review summarizes key updates from 2023 to 2024, focusing on surgical innovations, perioperative systemic ...
Katsutoshi Shoda, Yoshihiko Kawaguchi, Suguru Maruyama, Daisuke Ichikawa   +3 more
wiley   +1 more source

Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma

European Medical Journal, 2018
Immunotherapy has revolutionised the treatment of haematologic malignancies. Patients with relapsed/refractory non-Hodgkin’s lymphoma have poor response rates and short survival times when conventional cytotoxic chemotherapies are used.
Emily C. Ayers, Sunita D. Nasta
doaj  

Optimization of Culture Conditions for the Generation of Canine CD20-CAR-T Cells for Adoptive Immunotherapy. [PDF]

In Vivo, 2022
Sakai O, Yamamoto H, Igase M, Mizuno T.
europepmc   +1 more source

Donor Cell Cycling, Trafficking, and Accumulation during Adoptive Immunotherapy for Murine Lung Metastases [PDF]

, 2004
Joseph J. Skitzki, Ronald A. Craig, R Okuyama, Randall N. Knibbs, Kevin T. McDonagh, Alfred E. Chang, Lloyd M. Stoolman   +6 more
openalex   +1 more source

Molecular Engineering‐Boosted High‐Performance AIE Sonosensitizer for Cancer Sonodynamic‐Augmented Immunotherapy

Aggregate, EarlyView.
The development of sonodynamic immunotherapy with the evoking of immunogenic cell death presents high promise for cancer treatment in biosafe and penetrated manner. Based on engineering structure modulation by regulating intermolecular interaction and push‐pull electronic effect, high performance aggregation‐induced emission (AIE) sonosensitizer with ...
Chao Fu, Wei Zhao, Xionglei Wang, Xia He, Yuting Yin, Jiayi Li, Qiyun Deng, Caihong Yan, Yuli Yin, Zhiming Wang, Rong Hu   +10 more
wiley   +1 more source

Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy. [PDF]

J Virol
Wu C, Johnson NM, Yu S, Lo AS, Sahu GK, Marx PA, von Laer D, Skowron G, Geleziunas R, Shaw GM, Kaur A, Junghans RP, Braun SE.   +12 more
europepmc   +1 more source

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8⁺ antigen-specific T cells for adoptive immunotherapy. [PDF]

Mol Ther Methods Clin Dev, 2022
Lak S, Janelle V, Djedid A, Boudreau G, Brasey A, Lisi V, Smaani A, Carli C, Busque L, Lavallée VP, Delisle JS.   +10 more
europepmc   +1 more source

Rapid enrichment of human papillomavirus (HPV)‐specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer [PDF]

, 2004
Annemieke de Jong, Jeanette M. van der Hulst, Gemma G. Kenter, Jan W. Drijfhout, Kees L. M. C. Franken, Pieter Vermeij, Rienk Offringa, Sjoerd H. van der Burg, Cornelis J.M. Melief   +8 more
openalex   +1 more source